Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ep-7041
1. Ep-7041
2. 1803270-60-1
3. Bke5cvp3fs
4. (2s,3r)-3-((2-aminopyridin-4-yl)methyl)-1-(((1r)-1-cyclohexylethyl)carbamoyl)-4-oxoazetidine-2-carboxylic Acid
5. (2s,3r)-3-[(2-aminopyridin-4-yl)methyl]-1-[[(1r)-1-cyclohexylethyl]carbamoyl]-4-oxoazetidine-2-carboxylic Acid
6. (2s,3r)-3-[(2-aminopyridin-4-yl)methyl]-1-{[(1r)-1-cyclohexylethyl]carbamoyl}-4-oxoazetidine-2-carboxylic Acid
7. Refchem:137078
8. Frunexian (usan)
9. Frunexian [usan]
10. Frunexian [inn]
11. Orb2277627
12. Chembl5314583
13. Schembl16997955
14. Gtpl11990
15. Ep 7041 [who-dd]
16. Bdbm50621716
17. Ep7041
18. Da-73563
19. Hy-156613
20. Cs-0886205
21. D12563
22. 2-azetidinecarboxylic Acid, 3-[(2-amino-4-pyridinyl)methyl]-1-[[[(1r)-1-cyclohexylethyl]amino]carbonyl]-4-oxo-, (2s,3r)-
| Molecular Weight | 374.4 g/mol |
|---|---|
| Molecular Formula | C19H26N4O4 |
| XLogP3 | 2.6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 5 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 126 |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 578 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
53
PharmaCompass offers a list of Frunexian API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Frunexian manufacturer or Frunexian supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Frunexian manufacturer or Frunexian supplier.
A Frunexian manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Frunexian, including repackagers and relabelers. The FDA regulates Frunexian manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Frunexian API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Frunexian supplier is an individual or a company that provides Frunexian active pharmaceutical ingredient (API) or Frunexian finished formulations upon request. The Frunexian suppliers may include Frunexian API manufacturers, exporters, distributors and traders.
Frunexian Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Frunexian GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Frunexian GMP manufacturer or Frunexian GMP API supplier for your needs.
A Frunexian CoA (Certificate of Analysis) is a formal document that attests to Frunexian's compliance with Frunexian specifications and serves as a tool for batch-level quality control.
Frunexian CoA mostly includes findings from lab analyses of a specific batch. For each Frunexian CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Frunexian may be tested according to a variety of international standards, such as European Pharmacopoeia (Frunexian EP), Frunexian JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Frunexian USP).
